December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

100.23 +1.58 (+1.61%)
Streaming Delayed Price Updated: 10:31 AM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
21 22 Next >
News headline image
BOSTON SCIENTIFIC CORP (NYSE:BSX) showing some interesting technicals. Here's why. ↗
BOSTON SCIENTIFIC CORP (NYSE:BSX) has a good technical rating of 10 out of 10 and could possibly break out. 
Via Chartmill
News headline image
Critical Insights From Boston Scientific Analyst Ratings: What You Need To Know ↗
 
Via Benzinga
News headline image
Performance Comparison: Boston Scientific And Competitors In Health Care Equipment &amp; Supplies Industry ↗
 
Via Benzinga
News headline image
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $5,900 Today ↗
 
Via Benzinga
News headline image
Peering Into Boston Scientific's Recent Short Interest ↗
 
Via Benzinga
News headline image
Staar Surgical Stock Earns RS Rating Upgrade ↗
On Thursday, lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 87 from 77. 
Via Investor's Business Daily
News headline image
7 Biotech Stocks to Boost Your Portfolio to Peak Health ↗
With biotech stocks commanding a permanently relevant narrative, you can’t afford to ignore these highly endorsed ideas. 
Via InvestorPlace
News headline image
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $6,100 Today ↗
 
Via Benzinga
News headline image
Unveiling 21 Analyst Insights On Boston Scientific ↗
 
Via Benzinga
News headline image
3 Record-Breaking Stocks With More Room to Run ↗
These three top record-breaking stocks have more upside ahead, driven by analysts' Strong Buy recommendations. 
Via InvestorPlace
Boston Scientific to Acquire Silk Road Medical in $1.16 billion USD Merger and Acquisition (M&A) Deal
Via AB Newswire
News headline image
Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical's $1.3B Deal ↗
Boston Scientific to acquire Silk Road Medical for $1.26 billion, enhancing its vascular portfolio with Silk Road's TCAR system, a breakthrough in stroke prevention. Transaction closes in H2 2024. 
Via Benzinga
News headline image
Why Is Silk Road Medical (SILK) Stock Up 24% Today? ↗
Silk Road Medical stock is up on Tuesday after Boston Scientific announced its acquiring the company in a $1.26 billion deal. 
Via InvestorPlace
News headline image
Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover ↗
The deal focuses on the company's stroke prevention product for patients with carotid artery disease. 
Via Investor's Business Daily
News headline image
Check Out What Whales Are Doing With BSX ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Boston Scientific? ↗
 
Via Benzinga
News headline image
If You Invested $100 In This Stock 10 Years Ago, You Would Have $600 Today ↗
 
Via Benzinga
News headline image
Decoding 18 Analyst Evaluations For Boston Scientific ↗
 
Via Benzinga
News headline image
Silk Road Medical Announces Definitive Agreement to be Acquired by Boston Scientific
From Silk Road Medical
Via GlobeNewswire
News headline image
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention. 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years ↗
 
Via Benzinga
News headline image
Jim Cramer Recommends Buying This Sports Betting Company's Stock: 'I Think It's Terrific' ↗
Sports betting app DraftKings is "terrific," Cramer says. The company recently reported Q1 revenue of $1.18 billion, up 53% year-over-year. 
Via Benzinga
News headline image
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Boston Scientific's Upside With Cardiology Devices Drives Momentum ↗
Mizuho Securities raises target for Boston Scientific, predicting double-digit growth in cardiology. Surge in Farapulse adoption and Watchman FLX upside driving momentum. 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
MarketBeat Week in Review – 4/29 - 5/3
Apple, Amgen, and a weak jobs report helped move the market higher as investors temporarily looked past the possibility of no interest rate cuts in 2024 
Via MarketBeat
Topics Economy Stocks
News headline image
Citi Just Raised Its Price Target on These 3 Stocks ↗
Discover the three stocks enjoying boosted Citi price targets. Analysts believe they are primed for success, so it's time to start buying. 
Via InvestorPlace
News headline image
Needham Just Boosted Its Price Target on These 3 Stocks ↗
Amidst the uncertainty in the market at this time, it is best to rely on Needham price targets to make informed decisions. 
Via InvestorPlace
News headline image
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook. 
Via MarketBeat
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.